Dorsomorphin (Compound C): AMPK and BMP Inhibition in Muscle Metabolism and Disease Research

Introduction

The landscape of metabolic and cellular signaling research has been transformed by small-molecule modulators that allow precise dissection of intricate pathways. Dorsomorphin (Compound C) (SKU: B3252) stands at the forefront as a potent, reversible, ATP-competitive inhibitor of AMP-activated protein kinase (AMPK) and bone morphogenetic protein (BMP) signaling. While Dorsomorphin's established roles in metabolic, autophagy, and differentiation assays are well-documented, emerging research—particularly in the context of muscle metabolism and disease—demands a deeper mechanistic exploration. This article provides a comprehensive, scientifically rigorous analysis of Dorsomorphin, focusing on its unique advantages in studying AMPK and BMP/Smad pathways, its application in muscle atrophy and iron metabolism, and how it advances disease modeling beyond current protocols.

Molecular Mechanisms of Dorsomorphin (Compound C)

AMPK Signaling Pathway Inhibition

Dorsomorphin's primary mechanism is the selective, ATP-competitive inhibition of AMPK, a central energy sensor that integrates metabolic stress signals to regulate cellular energy homeostasis. With a Ki of 109 nM, Dorsomorphin exhibits substantially higher selectivity for AMPK over related kinases such as protein kinase A, protein kinase C, and Janus kinase 3. Upon binding, it reversibly inhibits AMPK kinase activity, leading to significant downstream effects:

• Suppression of ACC Phosphorylation: Acetyl-CoA carboxylase (ACC) is phosphorylated by AMPK under conditions of energy stress. Dorsomorphin reduces ACC phosphorylation by up to 80%, directly modulating lipid synthesis pathways and fatty acid oxidation.
• Autophagy Regulation: AMPK activation is known to promote autophagic proteolysis. By inhibiting AMPK, Dorsomorphin provides a tool to suppress autophagy, enabling researchers to dissect the role of AMPK in cellular quality control and homeostasis.

These effects are highly relevant for studies on metabolic disorders, muscle atrophy, and cancer, where AMPK-mediated energy regulation is often dysregulated.

BMP/Smad Signaling Pathway Modulation

Beyond AMPK inhibition, Dorsomorphin is a potent BMP signaling inhibitor. It blocks the phosphorylation of Smad 1/5/8, the transcriptional effectors of the BMP pathway, with an IC₅₀ of 0.47 μM. This dual action is particularly valuable for:

• Neural Stem Cell Differentiation: BMP inhibition supports neural induction and self-renewal in human embryonic stem cells, enabling advanced neurodevelopmental studies.
• Iron Metabolism Modulation: By reducing hepatic hepcidin transcription, Dorsomorphin increases serum iron levels, providing a model for studying iron homeostasis and related diseases.
• Inhibition of Heterotopic Ossification: BMP/Smad pathway suppression curtails pathological bone formation, relevant in musculoskeletal disease models.

Dorsomorphin in Muscle Metabolism: Bridging Mechanistic Insight and Translational Research

Targeting AMPK/PINK1/Parkin-Mediated Mitophagy in Muscle Atrophy

The regulation of mitophagy—selective degradation of damaged mitochondria—is a pivotal process in maintaining muscle health, particularly under metabolic stress (e.g., high-fat diets or sarcopenic obesity). A recent seminal study (Ren et al., Int J Biol Macromol, 2025) uncovered that activation of the AMPK/PINK1/Parkin pathway is crucial for mitigating muscle atrophy by promoting mitophagy, thereby restoring mitochondrial structure and function in skeletal muscle. The study demonstrated that Lycium barbarum polysaccharide (LBP) exerts therapeutic effects by engaging this pathway.

Notably, these beneficial effects were negated by the application of an AMPK inhibitor, directly implicating AMPK activity as essential for LBP-induced mitophagy and muscle preservation. Dorsomorphin (Compound C) thus emerges as an indispensable tool for:

• Specifically inhibiting AMPK to dissect its role in muscle metabolism and mitophagy
• Modeling the interplay between energy sensing, autophagy, and muscle atrophy
• Validating targets and pathways for anti-sarcopenic therapies

This application is distinct from generic metabolic assays, positioning Dorsomorphin as a pivotal reagent in translational muscle research that bridges molecular events to in vivo outcomes.

Autophagy Regulation and Cancer Research

Autophagy is increasingly recognized for its dual roles in cancer: promoting survival under stress yet also enabling cell death. By modulating AMPK, Dorsomorphin allows researchers to precisely control autophagic flux, supporting advanced oncology studies that go beyond cell viability endpoints to interrogate cellular quality control, stress adaptation, and metabolic vulnerabilities in tumor cells.

For a workflow-oriented guide on using Dorsomorphin in cancer and autophagy research, see this dossier. Our current analysis expands beyond protocol optimization to provide a mechanistic context for disease modeling, especially in muscle and iron-related disorders.

Comparative Analysis: Dorsomorphin Versus Alternative Inhibitors and Methods

Specificity and Reversibility

Unlike non-specific kinase inhibitors or genetic knockdowns, Dorsomorphin provides a reversible, cell-permeable means to selectively inhibit AMPK and BMP signaling. This selectivity is critical for dissecting pathway cross-talk and temporal dynamics in energy and differentiation studies.

While prior articles, such as the evidence-based scenario guide, focus on Dorsomorphin's practical utility in cell-based assays, here we emphasize its unique value in modeling disease-specific mechanisms—such as the disruption of AMPK-driven mitophagy in muscle degeneration—thereby enabling hypothesis-driven experimental designs that more closely mimic human pathophysiology.

Integration with Genetic and Nutritional Interventions

Dorsomorphin can be used in combination with siRNA, CRISPR, or nutritional interventions (e.g., high-fat diet models) to simulate complex disease states. Its rapid, reversible action allows for temporal control that genetic models cannot achieve, making it ideal for time-course studies and dynamic pathway interrogation.

Advanced Experimental Applications

Inhibition of AMPK Activity in Hepatocytes and HeLa Cells

Dorsomorphin consistently inhibits AMPK activity in hepatocyte and HeLa cell models, making it invaluable for metabolic flux and lipid synthesis studies. Its ability to suppress downstream ACC phosphorylation and autophagic proteolysis enables high-resolution mapping of metabolic and catabolic responses to energy stress.

BMP4-Induced SMAD Phosphorylation Inhibition and Stem Cell Research

By inhibiting BMP4-induced SMAD 1/5/8 phosphorylation, Dorsomorphin promotes neural induction and self-renewal in human pluripotent stem cells. This property is leveraged in regenerative medicine and developmental biology, supporting protocols where precise control of differentiation pathways is required.

Iron Metabolism Modulation in Animal Models

Dorsomorphin's capacity to reduce hepatic hepcidin gene transcription—thereby increasing serum iron—positions it as a tool for studying iron homeostasis and related disorders. In vivo, doses of 10 mg/kg (intraperitoneal) have been validated for modulating iron levels and hepcidin expression, enabling translational studies in anemia and iron-loading conditions.

Dorsalization in Zebrafish Embryos

Beyond mammalian models, Dorsomorphin is used to induce dorsalization in zebrafish embryos, providing insights into early developmental signaling and BMP pathway dynamics. This enables modeling of congenital disorders and pathway-targeted drug development.

Technical Guidance and Best Practices

• Solubility: Dorsomorphin is insoluble in water and ethanol, but dissolves in DMSO at concentrations ≥8.49 mg/mL (with warming and sonication).
• Storage: Store solid at -20°C. Use solutions promptly; avoid long-term storage.
• Recommended concentrations: 4–40 μM for cell culture; 10 mg/kg for animal studies.

For validated workflows and troubleshooting, see the scenario-driven guide. This current article, however, extends the discussion to translational applications and mechanistic exploration in disease models, which are often underrepresented in standard protocols.

Content Differentiation: Addressing Gaps in the Existing Literature

While previous articles emphasize protocol optimization, scenario-based decision-making, and broad overviews of Dorsomorphin’s biochemical properties, this article uniquely focuses on:

• Connecting AMPK and BMP inhibition to muscle metabolism and disease modeling, with a specific emphasis on mitophagy and iron homeostasis
• Integrating recent mechanistic discoveries (e.g., the role of AMPK/PINK1/Parkin-mediated mitophagy in muscle atrophy)
• Providing translational insights for researchers seeking to model human disease mechanisms, rather than purely optimizing in vitro workflows

This depth enables a more hypothesis-driven use of Dorsomorphin in advanced biomedical research, positioning it not only as a protocol reagent but as a strategic tool for unraveling complex pathophysiological processes.

Conclusion and Future Outlook

Dorsomorphin (Compound C) is more than a selective ATP-competitive AMPK inhibitor; it is a multipurpose modulator that bridges cellular signaling, disease modeling, and translational research. Its dual action on AMPK and BMP/Smad pathways supports advanced investigations into autophagy regulation, iron metabolism modulation, and neural stem cell differentiation. Recent findings—such as the critical role of AMPK in muscle mitophagy and atrophy (as demonstrated in Ren et al., 2025)—underscore Dorsomorphin’s value in therapeutic target validation and disease mechanism elucidation.

As research progresses into metabolic disease, cancer, and regenerative medicine, Dorsomorphin offered by APExBIO will remain a cornerstone tool. Researchers are encouraged to harness its unique properties not only for pathway inhibition but for building sophisticated disease models that advance the field toward precision therapeutics.

For further technical details and purchasing, visit the Dorsomorphin (Compound C) product page.